Frank Verwiel

CIK 1545794 · last filed 2026-06-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$425.6K

Companies

3

Total Filings

25

Lifetime Open-Market Net

-$37.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NTLA Director 35,148 $12.11 $425.6K -$37.6K 11 2026-06-10
ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Director $0 6 2020-01-29
AveXis, Inc. (AVXS) Delisted Director 0 $0 4 2018-05-15

Recent Filings · Page 2 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-01-25 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Grant (A) $0 EDGAR
2018-05-21 NTLA Grant (A) $0 EDGAR
2018-05-15 AveXis, Inc. (AVXS) Delisted Disp (D) −1,106 $0 EDGAR
2018-03-30 AveXis, Inc. (AVXS) Delisted Grant (A) +1,106 $0 EDGAR
2018-02-13 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Grant (A) $0 EDGAR
2017-07-25 NTLA Grant (A) $0 EDGAR
2017-06-01 AveXis, Inc. (AVXS) Delisted Grant (A) $0 EDGAR
2017-01-19 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Grant (A) $0 EDGAR
2016-02-12 AveXis, Inc. (AVXS) Delisted Grant (A) $0 EDGAR
2016-01-27 ACHILLION PHARMACEUTICALS INC (ACHN) Delisted Grant (A) $0 EDGAR
Showing 1120 of 25
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.